Clinical Trial Update: A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex [Phase 2]

View source ↗

Summary

Phase II placebo-controlled trial evaluating Topical TolaSure for aggregated mutant keratin in Epidermolysis Bullosa Simplex; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epidermolysis Bullosa Simplex

Drugs mentioned

• TolaSure

Snippet

Sponsor: BioMendics, LLC | Conditions: Epidermolysis Bullosa Simplex | Phase 2 | Status: RECRUITING